OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study
Aliza Hussain, Caroline Sun, Elizabeth Selvin, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 2, pp. e53-e64
Open Access | Times Cited: 26
Aliza Hussain, Caroline Sun, Elizabeth Selvin, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 2, pp. e53-e64
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review
Stefan Zivkovic, Gorica Marić, Nataša Cvetinovic, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1517-1517
Open Access | Times Cited: 29
Stefan Zivkovic, Gorica Marić, Nataša Cvetinovic, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1517-1517
Open Access | Times Cited: 29
New Therapies for Lowering Triglyceride-Rich Lipoproteins
Robert S. Rosenson, Aleesha Shaik, Wen‐Liang Song
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 18, pp. 1817-1830
Open Access | Times Cited: 47
Robert S. Rosenson, Aleesha Shaik, Wen‐Liang Song
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 18, pp. 1817-1830
Open Access | Times Cited: 47
Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review
Radu Andy Sascău, Alexandra Clément, Rodica Radu, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1774-1774
Open Access | Times Cited: 46
Radu Andy Sascău, Alexandra Clément, Rodica Radu, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1774-1774
Open Access | Times Cited: 46
Remnant cholesterol in patients admitted for acute coronary syndromes
Alberto Cordero, Belén Álvarez Álvarez, David Escribano, et al.
European Journal of Preventive Cardiology (2022) Vol. 30, Iss. 4, pp. 340-348
Closed Access | Times Cited: 23
Alberto Cordero, Belén Álvarez Álvarez, David Escribano, et al.
European Journal of Preventive Cardiology (2022) Vol. 30, Iss. 4, pp. 340-348
Closed Access | Times Cited: 23
Management of dyslipidemia in coronary artery disease: the present and the future
Kyriakos Dimitriadis, Panagiotis Theofilis, Panagιotis Iliakis, et al.
Coronary Artery Disease (2024) Vol. 35, Iss. 6, pp. 516-524
Closed Access | Times Cited: 4
Kyriakos Dimitriadis, Panagiotis Theofilis, Panagιotis Iliakis, et al.
Coronary Artery Disease (2024) Vol. 35, Iss. 6, pp. 516-524
Closed Access | Times Cited: 4
Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis
Jivani M. Gengatharan, Michal K. Handzlik, Zoya Y Chih, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 4
Jivani M. Gengatharan, Michal K. Handzlik, Zoya Y Chih, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 4
Discordant High Remnant Cholesterol With LDL-C Increases the Risk of Stroke: A Chinese Prospective Cohort Study
Minghui Han, Keyong Huang, Chong Shen, et al.
Stroke (2024) Vol. 55, Iss. 8, pp. 2066-2074
Closed Access | Times Cited: 3
Minghui Han, Keyong Huang, Chong Shen, et al.
Stroke (2024) Vol. 55, Iss. 8, pp. 2066-2074
Closed Access | Times Cited: 3
Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and effects of antisense knockdown of apoCIII
Xueying Peng, Zeqin Lian, Veronica O’Brien, et al.
Journal of Lipid Research (2025), pp. 100763-100763
Open Access
Xueying Peng, Zeqin Lian, Veronica O’Brien, et al.
Journal of Lipid Research (2025), pp. 100763-100763
Open Access
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement
Stefano Romeo, Antonio Vidal‐Puig, Mansoor Husain, et al.
European Heart Journal (2025)
Open Access
Stefano Romeo, Antonio Vidal‐Puig, Mansoor Husain, et al.
European Heart Journal (2025)
Open Access
Keeping remnants in perspective
Jan Borén, Chris J. Packard
European Heart Journal (2021) Vol. 42, Iss. 42, pp. 4333-4335
Open Access | Times Cited: 16
Jan Borén, Chris J. Packard
European Heart Journal (2021) Vol. 42, Iss. 42, pp. 4333-4335
Open Access | Times Cited: 16
Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome
Zeqin Lian, Xiaoyuan Dai Perrard, Antu Antony, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 5, pp. 460-475
Open Access | Times Cited: 5
Zeqin Lian, Xiaoyuan Dai Perrard, Antu Antony, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 5, pp. 460-475
Open Access | Times Cited: 5
Targeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside
Ping Ling, Xueying Zheng, Sihui Luo, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 9, pp. 2020-2034
Closed Access | Times Cited: 11
Ping Ling, Xueying Zheng, Sihui Luo, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 9, pp. 2020-2034
Closed Access | Times Cited: 11
Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies
Yun Tian, Wen‐Li Wu, Qin Li, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 4
Yun Tian, Wen‐Li Wu, Qin Li, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 4
Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension
Fangfang Xu, Lijun Shen, Yong‐Guang Yang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1647-1655
Open Access | Times Cited: 4
Fangfang Xu, Lijun Shen, Yong‐Guang Yang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1647-1655
Open Access | Times Cited: 4
Application of sphingolipid-based nanocarriers in drug delivery: an overview
Samarth Kumar, Ajit Singh, Prachi Pandey, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 8, pp. 619-637
Closed Access | Times Cited: 1
Samarth Kumar, Ajit Singh, Prachi Pandey, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 8, pp. 619-637
Closed Access | Times Cited: 1
Analysis of influential factors of stent-related adverse events after percutaneous coronary intervention more than twice: a single-center retrospective study
Jing Li, Liang Yu, Pengfei Chen
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Jing Li, Liang Yu, Pengfei Chen
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
Saeed Shoar, Waleed Ikram, Ahmed Ali Shah, et al.
Reviews in Cardiovascular Medicine (2021) Vol. 22, Iss. 2, pp. 295-295
Open Access | Times Cited: 10
Saeed Shoar, Waleed Ikram, Ahmed Ali Shah, et al.
Reviews in Cardiovascular Medicine (2021) Vol. 22, Iss. 2, pp. 295-295
Open Access | Times Cited: 10
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Dan Atar, Gisle Langslet, Serena Tonstad
Kardiologia Polska (2022) Vol. 80, Iss. 7-8, pp. 741-749
Open Access | Times Cited: 6
Dan Atar, Gisle Langslet, Serena Tonstad
Kardiologia Polska (2022) Vol. 80, Iss. 7-8, pp. 741-749
Open Access | Times Cited: 6
Cholesterol paradox in the community-living old adults: is higher better?
Shengshu Wang, Shanshan Yang, Chun-Jiang PAN, et al.
Journal of Geriatric Cardiology (2023) Vol. 20, Iss. 12, pp. 837-844
Open Access | Times Cited: 3
Shengshu Wang, Shanshan Yang, Chun-Jiang PAN, et al.
Journal of Geriatric Cardiology (2023) Vol. 20, Iss. 12, pp. 837-844
Open Access | Times Cited: 3
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content
Alessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Atherosclerosis (2022) Vol. 362, pp. 38-46
Closed Access | Times Cited: 4
Alessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Atherosclerosis (2022) Vol. 362, pp. 38-46
Closed Access | Times Cited: 4
Hypercholesterolemia
Ali Agha, Christie M. Ballantyne
Contemporary cardiology (2022), pp. 61-71
Closed Access | Times Cited: 3
Ali Agha, Christie M. Ballantyne
Contemporary cardiology (2022), pp. 61-71
Closed Access | Times Cited: 3
A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study
Bruno Bohn, Pamela L. Lutsey, Weihong Tang, et al.
Journal of Proteomics (2022) Vol. 272, pp. 104788-104788
Open Access | Times Cited: 3
Bruno Bohn, Pamela L. Lutsey, Weihong Tang, et al.
Journal of Proteomics (2022) Vol. 272, pp. 104788-104788
Open Access | Times Cited: 3
Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations
Kui Deng, Xiong‐Fei Pan, Markus Voehler, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 10
Open Access
Kui Deng, Xiong‐Fei Pan, Markus Voehler, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 10
Open Access
Evolving Therapeutic Targets
Aliza Hussain, Christie M. Ballantyne
Elsevier eBooks (2023), pp. 268-274.e1
Closed Access
Aliza Hussain, Christie M. Ballantyne
Elsevier eBooks (2023), pp. 268-274.e1
Closed Access
Metabolic syndrome: prospects for the use of angiopoetin-like proteins type 3 and 4 for the diagnosis of metabolic disorders
В. А. Александров
Meditsinskiy sovet = Medical Council (2023), Iss. 16, pp. 68-75
Open Access
В. А. Александров
Meditsinskiy sovet = Medical Council (2023), Iss. 16, pp. 68-75
Open Access
